(ALMIB) Amoeba - Ratings and Ratios

Amoéba S.A. specializes in developing biological biocides to mitigate microbiological risks across water treatment, agriculture, and public health sectors. The company leverages the unique properties of the amoeba Willaertia magna C2c Maky to create eco-friendly solutions for controlling microbial contamination. Founded in 2010 and headquartered in Chassieu, France, Amoéba positions itself as a pioneer in sustainable biocide technology, offering alternatives to traditional chemical-based treatments. The companys focus on environmentally responsible products aligns with growing global demand for green chemistry solutions.

From a technical perspective, Amoébas stock (ALMIB:PA) shows a 20-day average volume of 80,185 shares, with a last price of 0.84 EUR. The stock is currently trading below its 20-day (0.89) and 50-day (0.89) moving averages but above its 200-day moving average (0.65). The ATR of 0.04 indicates low volatility. On the fundamental side, the company has a market cap of 44.96M EUR, with a P/B ratio of 3.44 and a P/S ratio of 412.48. The RoE stands at 56.92%, reflecting efficient equity utilization.

Ticker Symbol: ALMIB | Exchange: PA | Type: Common Stock | Country Origin: France | GICS Sub Industry: Fertilizers & Agricultural Chemicals

3-Month Forecast: Based on technical and fundamental data, ALMIB is expected to face resistance at the 0.89 level, with potential upside to 1.00 if resistance is breached. Conversely, failure to maintain momentum could result in a pullback to the 0.65 support level. Fundamental trends suggest continued focus on market penetration and product adoption, which could drive valuation adjustments.